Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
All content for IPWatchdog Unleashed is the property of Gene Quinn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
Patent Monetization: Assessing Today’s Environment and Tomorrow’s Prospects
IPWatchdog Unleashed
54 minutes
4 months ago
Patent Monetization: Assessing Today’s Environment and Tomorrow’s Prospects
To successfully monetize a patent portfolio, it is necessary to identify the value within the portfolio and to put in the work to prove to third parties and potential partners that that value exists. But even then, even when all the hard work has been done, after quality assets have been obtained, after evidence of use has been gathered and negotiations have begun, there are no guarantees. This week on IPWatchdog Unleashed we enter the world of patent monetization, with a conversation about p...
IPWatchdog Unleashed
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
